Safety and efficacy of the epoetin kappa on anemia and inflammation in hemodialysis patients
Not Applicable
- Conditions
- ephrogenic anemia patients undergoing hemodialysis
- Registration Number
- JPRN-UMIN000009253
- Lead Sponsor
- Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients for whom Epoetin Kappa is contraindicated 2. Patient deemed by investigator to be unsuitable for participation in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method